Dose-escalated radiotherapy for clinically localized and locally advanced prostate cancer-Reference-Cited by-同舟云学术

Dose-escalated radiotherapy for clinically localized and locally advanced prostate cancer

Published:2023-03-08 Issue:3 Volume:2023 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Kim Sunghyun¹,Kong Jee Hyun²³,Lee YoHan¹,Lee Jun Young³⁴,Kang Tae Wook⁵,Kong Tae Hoon⁶,Kim Myung Ha⁷,You Sei Hwan¹³

Affiliation:

1. Department of Radation Oncology; Yonsei University Wonju College of Medicine; Wonju Korea, South

2. Department of Hematology-Oncology, Division of Internal Medicine; Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine; Wonju Korea, South

3. Center of Evidence Based Medicine, Institute of Convergence Science; Yonsei University; Seoul Korea, South

4. Department of Nephrology; Yonsei University Wonju College of Medicine; Wonju Korea, South

5. Department of Urology; Yonsei University Wonju College of Medicine; Wonju Korea, South

6. Department of Otorhinolaryngology Head and neck surgery; Yonsei University Wonju College of Medicine; Wonju Korea, South

7. Yonsei Wonju Medical Library; Yonsei University Wonju College of Medicine; Wonju Korea, South

Publisher

Wiley

Subject

Pharmacology (medical)

Reference114 articles.

1. Quality of life in patients with low-risk prostate cancer treated with hypofractionated vs conventional radiotherapy: a phase 3 randomized clinical trial;Bruner;JAMA,2019

2. Randomized phase III noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancer;Lee;Journal of Clinical Oncology,2016

3. Randomised pilot study of dose escalation using conformal radiotherapy in prostate cancer: long-term follow-up;Creak;British Journal of Cancer,2013

4. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects;Dearnaley;British Journal of Cancer,2005

5. The impact of clinical factors on the development of late radiation toxicity: results from the Medical Research Council RT01 trial (ISRCTN47772397);Barnett;Clinical Oncology,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Highlights from the 2024 ASCO Genitourinary Symposium: focus on urothelial and prostate cancer;Expert Review of Anticancer Therapy;2024-06-27

2. Focal brachytherapy as definitive treatment for localized prostate cancer: A systematic review and meta-analysis;Brachytherapy;2024-05

3. How does dose-escalated radiotherapy compare with conventional dose radiotherapy for men with localized prostate cancer?;Cochrane Clinical Answers;2024-03-19

4. Review of Current Treatment Intensification Strategies for Prostate Cancer Patients;Cancers;2023-11-28

5. Interpretation of wide confidence intervals in meta-analytic estimates: Is the ‘Absence of Evidence’ ‘Evidence of Absence’?;2023-07-14